Notice: Revision to the Guidance Document: Management of Drug Submissions and Applications
Health Canada is revising the Guidance Document entitled: The Management of Drug Submissions and Applications (MDSA). This document provides sponsors and Health Canada staff of the Therapeutic Products Directorate, the Biologic and Radiopharmaceutical Drugs Directorate, the Natural and Non-Prescription Health Products Directorate (Non-Prescription Drugs Evaluation Division), and the Marketed Health Products Directorate with operational direction and guidance regarding the way in which drug submissions, applications or post-market documents submitted to Health Canada are managed.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice: Revision to the Guidance Document: Management of Drug Submissions and ApplicationsHTMLEnglish publication HTML
-
Notice: Revision to the Guidance Document: Management of Drug Submissions and ApplicationsHTMLFrench publication HTML
Similar records